Journal article
Translational molecular imaging in exocrine pancreatic cancer
- Abstract:
- Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancer cases. Late diagnosis and failure of chemo- and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we will make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Springer Publisher's website
- Journal:
- European Journal of Nuclear Medicine and Molecular Imaging Journal website
- Volume:
- 45
- Issue:
- 13
- Pages:
- 2442–2455
- Publication date:
- 2018-09-17
- Acceptance date:
- 2018-08-18
- DOI:
- EISSN:
-
1619-7089
- ISSN:
-
1619-7070
- Source identifiers:
-
912175
Item Description
- Keywords:
- Pubs id:
-
pubs:912175
- UUID:
-
uuid:c9aaba15-d8e2-4246-a5bf-6b1c20df1949
- Local pid:
- pubs:912175
- Deposit date:
- 2018-09-06
Terms of use
- Copyright holder:
- Cornelissen et al
- Copyright date:
- 2018
- Notes:
- © The Author(s) 2018. This article is distributed under the terms of the Creative Commons At tribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record